Palliative care 2017
New agents……..
• Trastuzumab (anti-HER-2) • Panitumumab (anti-EGFR) • Gefitinib (EGFR-inhibitor) • Erlotinib (EGFR-inhibitor) • PARB inhibitors • PD-1 and PD-L1 inhibitors
Made with FlippingBook HTML5
New agents……..
• Trastuzumab (anti-HER-2) • Panitumumab (anti-EGFR) • Gefitinib (EGFR-inhibitor) • Erlotinib (EGFR-inhibitor) • PARB inhibitors • PD-1 and PD-L1 inhibitors
Made with FlippingBook HTML5